Author(s): Rolfs, Prof. Arndt, MD, Hermann, Andreas, MD, Lukas, Jan, PhD, Frech, Moritz J, PhD, Iwanov, Katharina, Petters, Janine, Völkner, Christin, Cimmaruta, Chiara, Chang, ML, Knuebel, G, Escobar, HM
Induced pluripotent stem cells (iPSCs) represent excellent in vitro models to study rare diseases and perform high-throughput drug screening.
Induced pluripotent stem cells (iPSCs) represent excellent in vitro models to study rare diseases and perform high-throughput drug screening. CENTOGENE has established iPSC technology for rare monogenetic diseases in its Rostock headquarters based on patient-derived fibroblasts.
Read publication
